Lung cancer is the leading cause of cancer deaths in the United States and affects over 200,000 Americans a year. Early detection and rapid diagnosis are key to overcoming this disease, and this is what Noah Medical seeks to provide with a robotic lung surgery system.
While medical science has made great strides in this area in recent years, Noah Medical's Galaxy system boasts numerous features which outshine competing offerings. Smaller and more mobile than most units, the device's robotic arm is able to fit on a single-wheeled cart, and its single-use probes remove the need for deep cleaning and the risk of cross-contamination. It also features visual sensors allowing surgeons to verify that its probe is within the target tissue, reducing the likelihood of false readings or surgical errors.
Having received FDA clearance for its device, Noah Medical has also received significant financial backing from investors. This will be used for the commercialization of its technology and scaling its production as demand for the product increases. With an innovative device meeting a pressing medical need, Noah Medical is positioning itself at the forefront of a fight against a deadly disease and is a leader in the medtech space.
Freddie
Company Specialist at Welcome to the Jungle
